News  ›  Article

Farris LLP: Vancouver's Law Firm


03 January 2008

Hector Mackay-Dunn, Q.C. Leads $915 Million Aspreva Deal

Victoria, B.C. Canada, January 3, 2008 Today, Aspreva Pharmaceuticals Corporation (NASDAQ: ASPV; TSX: ASV) closed its deal with Galenica Group (SWX: GALN) who will acquire all of Aspreva’s outstanding shares. The total value of the transaction is approximately US $915 million. Farris lawyers have represented Aspreva as its corporate counsel since inception, led by Hector MacKay-Dunn, Q.C., Trevor Scott, Ron Murray, and included solicitors, Peter Roth, Denise Nawata, and Bo Rothstein. Senior Partner, MacKay-Dunn, said “It has been an honour to have represented Aspreva over the years and we are delighted with their success. From incorporating Aspreva in 2002, raising private equity of more than CAD $76 million in 2004, their CAD $113 million IPO in 2005, to today being acquired for US $915 million is quite remarkable and a testament to the people at Aspreva and now Galenica.”

‹ Back